Gabriel Herrero-Beaumont Cuenca-rekin lankidetzan egindako argitalpenak (8)

1996

  1. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis

    Journal of Lipid Mediators and Cell Signalling, Vol. 13, Núm. 1, pp. 35-49

  2. Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells

    European Journal of Pharmacology, Vol. 302, Núm. 1-3, pp. 191-197

1995

  1. IL-1β and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells

    Clinical and Experimental Immunology, Vol. 99, Núm. 3, pp. 364-368

1994

  1. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis

    Agents and Actions, Vol. 41, Núm. 3-4, pp. 171-178

1992

  1. Involvement of platelet‐activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits

    Clinical & Experimental Immunology, Vol. 88, Núm. 2, pp. 318-323

1990

  1. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response

    Journal of Lipid Mediators

1988

  1. Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells

    Immunology, Vol. 63, Núm. 1, pp. 87-92

1987

  1. The role of circulating immune complexes and the liver in the development of IgA nephropathy in mice.

    Seminars in nephrology, Vol. 7, Núm. 4, pp. 289-293